NCT01878396View on ClinicalTrials.gov

Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors

UnknownOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2017

Conditions

Metastatic Melanoma

Interventions

DRUG

Anti-B-RAF

Trial Locations (1)

35128

RECRUITING

Vanna Chiarion-Sileni, MD, Padua

Sponsors

Collaborators (1)

Janssen Diagnostics, LLC

All Listed Sponsors

collaborator

Janssen Diagnostics, LLC

INDUSTRY

lead

Istituto Oncologico Veneto IRCCS

OTHER

NCT01878396 - Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors | Biotech Hunter | Biotech Hunter